JW Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

JW Asset Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-6,783	Closed	-$1.05M	–	46
2015 Q4	$1.05M	Sell	6,783 -13,529	-67%	-$1.98M	0.39%	25
2015 Q3	$2.9M	Sell	20,312 -29,738	-59%	-$4.16M	1.05%	22
2015 Q2	$7.19M	Sell	50,050 -29,635	-37%	-$4.23M	2.19%	10
2015 Q1	$11.2M	Sell	79,685 -27,246	-25%	-$4.19M	4.86%	7
2014 Q4	$15.8M	Buy	+106,931	New	+$15.7M	11.89%	1

Other funds holding TARO

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GCM

Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JW Asset Management's TARO Position: Q1 2016 in Review

JW Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2016, closing a stake of 6,783 shares — an estimated $1.05M sold.

JW Asset Management first reported a position in TARO in Q4 2014 and held it in 5 quarters. The position peaked at $15.8M in Q4 2014. 167 funds tracked by Wall St. Rank hold TARO as of Q1 2016.

JW Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2016 after selling out during the quarter.
JW Asset Management sold 6,783 Taro Pharmaceutical Industries Ltd. shares in Q1 2016, an estimated $1.05M.
JW Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2014 and held it in 5 quarters.
JW Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $15.8M in Q4 2014.
167 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2016.

Based on JW Asset Management's 13F filing for Q1 2016, filed 12 May 2016.